NCT02582515View on ClinicalTrials.gov

Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Tourette DisorderChronic Tic Disorder
Interventions
DRUG

D-cycloserine

DRUG

Placebo

Trial Locations (1)

90024

UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02582515 - Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo | Biotech Hunter | Biotech Hunter